Crosstalk Between Matrix Metalloproteinases and Their Inducer EMMPRIN/CD147: a Promising Therapeutic Target for Intracerebral Hemorrhage
Translational Stroke Research · 2025-04 · 16 (2) · 557-567
DOI: 10.1007/s12975-023-01225-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Stroke Research, online erschienen am 15.12.2023. Verfasst von Yang Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Basigin, Matrix Metalloproteinases, Cerebral Hemorrhage. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 134 Literaturangaben.
Abstract (Originalsprache)
Intracerebral hemorrhage (ICH) is characterized by the disruption of cerebrovascular integrity, resulting in hematoma enlargement, edema formation, and physical damage in the brain parenchyma. Primary ICH also leads to secondary brain injury contributed by oxidative stress, dysregulated immune responses, and proteolysis. In this context, matrix metalloproteinases (MMPs) represent a ubiquitous superfamily of structurally related zinc-dependent endopeptidases capable of degrading all components of the extracellular matrix. They disrupt the blood-brain barrier and promote neuroinflammation. Importantly, several MMP members are upregulated following ICH, and members may have different functions at specific periods in ICH. Hence, the modulation and function of MMPs are more complex than expected. Extracellular matrix metalloproteinase inducer (EMMPRIN, CD147) is a transmembrane glycoprotein that induces the production of MMPs. In this review, we systematically discuss the biology and functions of MMPs and EMMPRIN/CD147 in ICH and the complex crosstalk between them.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Henan International Joint Laboratory of Intracerebral Hemorrhage and Brain Injury, Zhengzhou, Henan, China.
- Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. vyong@ucalgary.ca.
- Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. xuemengzhou@zzu.edu.cn.
- Henan International Joint Laboratory of Intracerebral Hemorrhage and Brain Injury, Zhengzhou, Henan, China. xuemengzhou@zzu.edu.cn.
Zitieren
APA
Liu, Y., Qi, L., Li, Z., Yong, V. W., & Xue, M. (2025). Crosstalk Between Matrix Metalloproteinases and Their Inducer EMMPRIN/CD147: a Promising Therapeutic Target for Intracerebral Hemorrhage. Translational Stroke Research, 16(2), 557-567. https://doi.org/10.1007/s12975-023-01225-6
Vancouver
Liu Y, Qi L, Li Z, Yong VW, Xue M. Crosstalk Between Matrix Metalloproteinases and Their Inducer EMMPRIN/CD147: a Promising Therapeutic Target for Intracerebral Hemorrhage. Translational Stroke Research. 2025;16(2):557-567. doi:10.1007/s12975-023-01225-6
BibTeX
@article{Liu2025,
author = {Liu, Yang and Qi, Lingxiao and Li, Zhe and Yong, V Wee and Xue, Mengzhou},
title = {Crosstalk Between Matrix Metalloproteinases and Their Inducer EMMPRIN/CD147: a Promising Therapeutic Target for Intracerebral Hemorrhage},
journal = {Translational Stroke Research},
year = {2025},
volume = {16},
number = {2},
pages = {557--567},
doi = {10.1007/s12975-023-01225-6}
}
EUVIMED